Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Pfenex is a clinical-stage biotechnology company developing and commercializing high-value and difficult to manufacture proteins.
Trovagene is a clinical-stage, precision medicine oncology therapeutics company.
OncoSec Medical is a biotechnology company that develops treatments for advanced stage skin cancer patients.
Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
Adamis Pharmaceuticals Corporation is a specialty biopharmaceuticals company focused on developing and commercializing products in the therapeutic areas of allergy and respiratory disease.
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
Illumina is a company that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function.
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines.
NuVasive is a medical device company developing minimally disruptive surgical products and procedurally integrated solutions for the spine.
Organovo develops a range of tissue and disease models for medical research and therapeutic applications.
Cidara is biotechnology focused on developing novel anti-infectives to address serious infections.